Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.34 |
| ▸ | HTR2A | P28223 | 1/20 | 0.34 |
| ▸ | HTR2C | P28335 | 1/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.34 |
| ▸ | HRH1 | P35367 | 1/20 | 0.34 |
| ▸ | DRD3 | P35462 | 1/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.34 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.34 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20544190 | 0.90 | CA1 (0.42) | TSHRSMN1; SMN2MEN1ALDH1A1KMT2A | |
| SCHEMBL10883690 | 0.89 | MAPT (0.47) | TSHRSMN1; SMN2MEN1ALDH1A1KMT2A | |
| SCHEMBL9507506 | 0.88 | MAPT (0.36) | TSHRSMN1; SMN2MEN1ALDH1A1KMT2A | |
| SCHEMBL29270013 | 0.88 | CA1 (0.50) | MAPTACE2CA1FDPSFAAH | |
| SCHEMBL29270086 | 0.87 | ACE2 (0.49) | MAPTACE2CA1FDPSFAAH | |
| SCHEMBL29270028 | 0.87 | ACE2 (0.49) | MAPTACE2CA1FDPSFAAH | |
| SCHEMBL7217926 | 0.87 | BLM (0.47) | TSHRSMN1; SMN2MEN1ALDH1A1KMT2A | |
| SCHEMBL29269976 | 0.87 | ACE2 (0.49) | MAPTACE2CA1FDPSFAAH | |
| SCHEMBL29270070 | 0.87 | ACE2 (0.49) | MAPTACE2CA1FDPSFAAH | |
| SCHEMBL3904364 | 0.84 | TSHR (0.44) | TSHRSMN1; SMN2MEN1ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 141 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12559703-B2 | Fragrance composition | GIVAUDAN SA (CH) | 2026-02-24 | — | — | US | claimed |
| US-20230151305-A1 | FRAGRANCE COMPOSITION | SA, GIVAUDAN (CH) | 2023-05-18 | — | — | US | claimed |
| EP-4146778-A1 | FRAGRANCE COMPOSITION | Givaudan SA (CH) | 2023-03-15 | — | — | EP | claimed |
| WO-2021224201-A1 | FRAGRANCE COMPOSITION | GIVAUDAN SA (CH) | 2021-11-11 | — | — | WO | claimed |
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| WO-2011101181-A1 | PERFUME COMPOSITIONS | HENKEL AG & CO. KGAA (DE) | 2011-08-25 | — | — | WO | claimed |
| EP-1948773-A1 | FRAGRANT CONSUMER PRODUCTS COMPRISING OXIDIZING AGENTS | Henkel AG & Co. KGaA (DE) | 2008-07-30 | — | — | EP | claimed |
| WO-2007054177-A1 | FRAGRANT CONSUMER PRODUCTS COMPRISING OXIDIZING AGENTS | HENKEL AG & CO. KGAA (DE) | 2007-05-18 | — | — | WO | claimed |
| EP-0098791-B1 | 2-METHYLPENTANOIC-ACID ESTERS WITH BRANCHED OR CARBOCYCLIC ALCOHOLS, THEIR PREPARATION AND USE AS PERFUMING AGENTS | Henkel Kommanditgesellschaft auf Aktien (DE) | 1986-03-05 | — | — | EP | claimed |
| EP-0098791-A1 | 2-Methylpentanoic-acid esters with branched or carbocyclic alcohols, their preparation and use as perfuming agents | Henkel Kommanditgesellschaft auf Aktien (DE) | 1984-01-18 | — | — | EP | claimed |
| EP-4709153-A1 | ANIMAL LITTER | Givaudan SA (CH) | 2026-03-18 | — | — | EP | disclosed |
| US-12577511-B2 | Agent containing emulsifier and microcapsules | HENKEL AG & CO. KGAA (DE) | 2026-03-17 | — | — | US | disclosed |
| US-12559703-B2 | Fragrance composition | GIVAUDAN SA (CH) | 2026-02-24 | — | — | US | disclosed |
| EP-4695016-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2026-02-18 | — | — | EP | disclosed |
| US-12497577-B2 | Method of countering malodour in a washing machine comprising the addition of a fragrance precursor | GIVAUDAN SA (CH) | 2025-12-16 | — | — | US | disclosed |
| EP-1948773-A1 | FRAGRANT CONSUMER PRODUCTS COMPRISING OXIDIZING AGENTS | Henkel AG & Co. KGaA (DE) | 2008-07-30 | — | — | EP | disclosed |
| WO-2007054177-A1 | FRAGRANT CONSUMER PRODUCTS COMPRISING OXIDIZING AGENTS | HENKEL AG & CO. KGAA (DE) | 2007-05-18 | — | — | WO | disclosed |
| EP-0098791-B1 | 2-METHYLPENTANOIC-ACID ESTERS WITH BRANCHED OR CARBOCYCLIC ALCOHOLS, THEIR PREPARATION AND USE AS PERFUMING AGENTS | Henkel Kommanditgesellschaft auf Aktien (DE) | 1986-03-05 | — | — | EP | disclosed |
| EP-0098791-A1 | 2-Methylpentanoic-acid esters with branched or carbocyclic alcohols, their preparation and use as perfuming agents | Henkel Kommanditgesellschaft auf Aktien (DE) | 1984-01-18 | — | — | EP | disclosed |
| EP-0098791-A1 | 2-Methylpentanoic-acid esters with branched or carbocyclic alcohols, their preparation and use as perfuming agents | Henkel Kommanditgesellschaft auf Aktien (DE) | 1984-01-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577511-B2 | Agent containing emulsifier and microcapsules | LIPA, CUTA, MGLL | TSHR 3633/4885SMN1; SMN2 1681/4885MEN1 1263/4885 |
| US-12559703-B2 | Fragrance composition | DHCR24, OPRD1, OR10J3 | TSHR 3559/4885SMN1; SMN2 3767/4885MEN1 3398/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.